Acurx‘s $1 million Bitcoin investment is a major shift in treasury handling. This Nasdaq listed biotech company is just one of the many firms investing in Bitcoin. This strategy fits a wider trend of companies adjusting to rising support for cryptocurrency and market volatility.
Please Read This: Top 3 Cryptocurrencies On The Verge Of New All-Time Highs
Acurx’s $1M investment in Bitcoin signals major trends for corporate cryptocurrency adoption
Strategic Treasury Management
Acurx Bitcoin investment follows market research. “As demand for Bitcoin grows, and so does its acceptance as a major and primary asset class, we believe that Bitcoin will serve as a strong treasury reserve asset for cash not needed over the next 12 to 18 months,” You can find out more about this by clicking here. David P. Luci, President & CEO of Acurx.
Acurx Bitcoin Investment Market and Corporate Bitcoin Strategies
Bitcoin has been a success for many companies. Acurx shares jumped 6.6% before market opening to $1.78. Smart asset placement is the key to this bitcoin investment strategy.
Please Read This: Currency: Rupee Fails To Rise Despite India Dumping the US Dollar
ETF Approval Effect
“With the recent approval of Bitcoin ETFs and the growing support from government agencies and institutional investors, it is a great addition to our treasury strategy. Its limited supply and inflation-resistant characteristics provide a functional store of value,” Luci pointed out that the Bitcoin strategy of their corporate choice was behind this decision.
Business Integration
Acurx Pharmaceuticals’ founders David P. Luci and Robert J. DeLuccia invested in Bitcoins. They founded Acurx Pharmaceuticals back in 2017. The company focuses on developing new antibiotics to treat tough bacteria infections. This is what the firm says. “is a finance strategy and has no impact on our overarching drug development plans,” Telling investors that their primary work remains the same.
Please Read This: What Nvidia’s Q3 Stock Drop Means for AI and Tech Investors
Nasdaq-listed pharmaceutical company purchases Bitcoins marks major changes in Treasury Management. Acurx’s decision shows Bitcoin’s role as a new reserve asset. More institutions and regulations are supporting Bitcoin. The move also shows how other businesses can combine standard business methods with new payment systems.
“This article is not financial advice.”
“Always do your own research before making any type of investment.”
“ItsDailyCrypto is not responsible for any activities you perform outside ItsDailyCrypto.”
Source: watcher.guru
